IQVIA Case Study Interview 2026: Hiring Process and Rounds

The IQVIA case interview is a pharma or biotech business problem that you drive yourself, and the IQVIA hiring process, or IQVIA recruitment process, wraps it in a screen and two interview rounds. The IQVIA consultant interview and the IQVIA associate consultant interview follow the same steps: in IQVIA's 2024 campus hiring for Singapore and Malaysia, Analyst, Associate Consultant and Consultant candidates all went through the same video screen, case rounds and partner interview, including experienced hires (the Consultant role asked for a top MBA or more than six years of consulting experience). Below is the IQVIA interview process stage by stage, the case types, the written case and a worked drug-launch case with the math.

How does the IQVIA interview process work?

You apply online, pass a recruiter or video screen, then sit two rounds: a case and a behavioral interview first, then three to four final interviews that add a written case. That is the sequence candidates report for IQVIA consulting roles, usually 3 to 4 weeks from first contact to offer. Click a stage to see what IQVIA tests there and the practice that matches it.

Interview process

From application to IQVIA offer

ApplyScreenBehavioralCaseFinalOffer

Apply to a consulting role

Apply on IQVIA's careers site to an Analyst, Associate Consultant or Consultant role in a consulting team.

Track your applications →Read this step ↓

Answer why IQVIA

One first-round interview is behavioral: why IQVIA, why consulting, a team you led, a conflict you handled.

Rehearse an IQVIA interview →Read this step ↓

Drive a pharma case

A 30-minute candidate-led case on a pharma or biotech problem. You ask for every number you need.

Practice a biopharma case for IQVIA →Read this step ↓

Clear the final round

Three to four interviews, including a written case where you read slides and recommend one action.

Run the case out loud →Read this step ↓

Get the decision

IQVIA usually replies within one to two weeks of each interview; the whole process runs 3 to 4 weeks.

Read this step ↓

Pass the screen

A 20 to 30 minute call or recorded video on your resume, why IQVIA and why healthcare. Drop your resume for a screen-ready grade.

Opening resume uploader...

Read this step ↓

IQVIA publishes no global interview guide; its careers site offers general interview tips only. The closest official description is its 2024 Spring campus announcement for Strategy Life Sciences Consulting in Singapore and Malaysia: a short video interview on Modern Hire, first and second round case interviews with consultants and managers, then a final fit interview with consulting partners. Those interviews ran from October 9 to December 15, 2023, with offers in December. Ask your recruiter which version your office runs.

How do you apply and check your IQVIA application status?

Apply through IQVIA's careers site, then track the application in its Workday candidate portal under My Applications. That is the hiring process IQVIA's candidate FAQ sets out (checked November 4, 2026): click Apply Now on a role, create an account in the candidate portal, and complete the application there. Its Talent Acquisition team reviews applications and sends updates to the email you applied with, so check your spam folder. IQVIA allows AI tools to tidy your resume but warns that false or exaggerated content can disqualify you, and most employees can refer you through its referral program.

IQVIA-style healthcare practice cases at a glance

How an IQVIA case works: it is a pharma or biotech business problem that you drive yourself, wrapped in a screen and two interview rounds.

Start free now: MedSuite Technologies Hospital Software Pricing is a McKinsey-style pricing case: a healthcare IT startup with a new hospital electronic health records platform must decide how to price it to maximize first-year revenue. It has 8 questions, 3 with math, 2 exhibits, and a median of 20 minutes across 18 completed voice runs. An AI interviewer runs it out loud, shows each exhibit when you reach it and scores the debrief. Your first full case is free when you create an account.

Case (style, industry)	Quant difficulty	Qualitative difficulty	The math you run	Median time
MedSuite Technologies Hospital Software Pricing (McKinsey, hospital software). 8 (3 with math), 2 exhibits.hospital softwareQuant difficulty mediumQualitative difficulty medium20 min· 18 voice runsTry free	medium	medium	Revenue at each price point, tiered pricing	20 min18 voice runs20 min, 18 voice runs	Try free
HarborHealth Acquisition of MedLink Virtual Care (BCG, digital health). 8 (2 with math), 4 exhibits.digital healthQuant difficulty mediumQualitative difficulty hard27 min· 28 voice runsTry free	medium	hard	EV/EBITDA multiple, maximum justified offer	27 min28 voice runs27 min, 28 voice runs	Try free
Mustard Clinic (McKinsey, healthcare). 8 (3 with math), 2 exhibits.healthcareQuant difficulty hardQualitative difficulty mediumFewer than 10 runsTry free	hard	medium	Average stay, cost saving, freed capacity	Fewer than 10 runsFewer than 10 runs	Try free
National Health System (Independent, health services). 8 (1 with math), 1 exhibit.health servicesQuant difficulty easyQualitative difficulty mediumFewer than 10 runsTry free	easy	medium	Older share, visits, specialists needed	Fewer than 10 runsFewer than 10 runs	Try free

Two are adapted from consulting club casebooks (Kellogg and INSEAD); the rest were written for Road to Offer. The library has no case in IQVIA's own style, so these are matched by case type to what IQVIA asks. None is IQVIA's own material. More are in the case library, 92 cases in all. Every debrief scores seven categories: structure (25% of the score), quantitative analysis (20%), business judgment (15%), and problem understanding, exhibit reading, communication and synthesis (10% each), with feedback on every question. Median times come from completed runs between June 25 and September 22, 2026, and count runs, not people.

How many interview rounds does IQVIA have?

Two rounds after the screen: a first round of two 30-minute interviews and a final round of three to four interviews. Candidates report this lineup for IQVIA consulting roles.

The screen

The screen checks your resume, your motivation and your basic fit before you reach a case. Candidates report "Tell me about yourself", "Why IQVIA?" and "Why healthcare consulting?" as the typical questions. If the screen is recorded, practise answering to a timer, since there is no one to give you cues.

The first round

Both interviews last about 30 minutes. One is a candidate-led case, the other covers your resume and behavioral questions. Treat the behavioral interview as a scored interview, not a chat: it is half of the round.

The final round

Three to four interviews, back to back: more advanced cases, more behavioral questions and the written case. Some candidate reports on Glassdoor describe extra steps in some offices, such as an aptitude test or a group case, so ask your recruiter for the exact lineup and prepare for the full version.

What is the IQVIA case interview format?

Candidate-led: you set the structure, choose the branch to test first, and ask for each number you need. Candidates say IQVIA interviewers may give an occasional prompt but expect you to drive the case. In practice you:

• Ask for a moment to structure before you talk
• Present a clear structure, then say which branch you will test first and why
• Request specific data ("Do we have the eligible patient population and the net price per patient?") instead of waiting for an exhibit
• Summarize as you go and say what you will do next
• Deliver a recommendation without being asked for one

If you have only practised interviewer-led, McKinsey-style cases, this is the adjustment to make: silence from the interviewer means keep going. If you have never run a case, learn the method first:

Learn the case method

One dense lesson, each step linked to the drill that trains it.

Start the free lesson

The content is where IQVIA differs from a generalist firm. Instead of "a widget maker's profits are down", you get "a biotech is deciding whether to launch a new therapy" or "a drugmaker needs to protect revenue after its patent expires". The structuring skills transfer; the data you ask for and the levers you pull are specific to life sciences. The life sciences consulting case interview guide covers the sector mechanics, and the healthcare case interview guide maps the payer, provider and pharma landscape these prompts sit in.

What case study questions does IQVIA ask?

Five recurring prompts: a drug launch decision, pricing and patent cliffs, portfolio and deal choices, plant capacity, and patient-based market sizing. Candidates report these themes for IQVIA, with typical asks:

1. Launch decision. A client holds a new therapy: bring it to market or not, and how? Weigh approval timing, rival products, how it reaches patients and what to charge. This is the case worked in full below.
2. Pricing and the patent cliff. Pick a price for a medicine, or defend sales once exclusivity ends. Your levers are payer rebates, formulary access and how fast generics arrive; the pharma case interview guide goes deeper.
3. Portfolio and deals. A drugmaker has limited research budget or an acquisition target in view. Rank the pipeline projects or judge whether the purchase is worth it.
4. Capacity. A manufacturer wonders whether to build out a plant and where output is getting stuck. Expect a mix of cost, throughput and risk questions.
5. Patient-based sizing. Count who could use a treatment, whether for a rare condition, a new vaccine or a new drug. Walk from disease prevalence to diagnosed and treated patients to a plausible share; the market sizing step by step guide drills the method.

For a portfolio rep on a biopharma client, try Aperture Laboratories, a drugmaker that must choose which projects to fund and which business to sell. It is original practice, not IQVIA material:

Practice a biopharma portfolio case for IQVIA

HealthcareHard

Start the biopharma case

What is the IQVIA written case?

A final-round exercise where you read a set of slides, pull out the insight that matters and recommend one strategic action. Candidates describe it as a simulation of an internal deliverable: you analyze the data, structure a recommendation and present it clearly under time pressure.

IQVIA does not publish a template for your answer. A five-slide deck works well under time pressure:

The written case interview guide has timed practice formats.

What behavioral questions does IQVIA ask?

Why IQVIA, why consulting, why healthcare, a walk through your resume, and stories about leading a team, handling conflict and solving a complex problem. That is the list candidates report; prepare 5 to 7 stories in the STAR format.

• Why IQVIA and why healthcare consulting. Tie your answer to IQVIA's data and analytics identity and to a real reason you want life sciences, not just "consulting".
• Teamwork and leadership. A time you led a team or worked across functions to hit a deadline.
• Conflict. A difficult stakeholder or teammate, what you did, and what changed.
• A complex problem. One analysis you owned from question to answer, with a number in the result.

Keep each story under two minutes and map it to the trait it proves, so you can pick the right one when the question comes. The ZS Associates case interview guide covers the same analytics-firm fit themes if you are recruiting at both.

What is IQVIA, and why are its cases about pharma?

IQVIA is a healthcare data, technology and analytics company, so its consulting cases come from pharma, biotech and medical technology clients. It was formed in October 2016 when Quintiles merged with IMS Health, is headquartered in Durham, North Carolina, and reported $16.31 billion of revenue for 2025 (results published February 5, 2026). Its 2025 annual report gives about 93,000 employees in more than 100 countries.

Its consulting teams sit next to the data and technology business, which is why the cases test whether you can reason through a launch, a price or a forecast for a drug, not whether you can recite a generic framework. The closest comparables are healthcare practices at firms like ZS and pricing specialists like Simon-Kucher; the Simon-Kucher case interview guide covers pricing cases in depth.

What pharma knowledge do you need for an IQVIA interview?

No science degree, but five basics: development phases, FDA approval, payer mix, patent expiry and the net revenue equation.

Drug development phases. Preclinical (lab and animal testing), Phase I (safety in a small healthy group), Phase II (efficacy and dosing in patients), Phase III (large-scale efficacy and safety), then FDA review of the New Drug Application or Biologics License Application, and Phase IV (post-market surveillance). Each phase costs more, and most candidates fail in Phase II or III, which is why a Phase III asset is valuable.

FDA approval. A drug must clear FDA review before it can be sold in the US. The label the FDA grants (which patients, which indication) defines the addressable market.

Payer mix. In the US, someone other than the patient usually pays. Commercial insurers, Medicare and Medicaid each negotiate differently, and a drug can be approved and still fail commercially if payers will not cover it or demand steep rebates. Access, not approval, often decides a launch.

Patent expiry. A drug has a patent-protected window to earn back its R&D. When exclusivity ends, generics or biosimilars enter and revenue can fall sharply, sometimes by most of its value within a year or two. Forecasting around this cliff is a recurring life sciences case.

The net revenue equation. Net revenue equals treated patients times net price per patient, where net price is list price minus discounts to payers and the channel. Profit is net revenue minus cost of goods (often low for small molecules, higher for biologics) minus the sales and marketing cost of reaching prescribers, against R&D that is largely sunk. With that equation, most IQVIA economics cases become arithmetic.

What does a worked IQVIA case study look like?

Here is a candidate-led drug-launch case solved end to end: about $360 million of peak revenue and $186 million of peak operating profit, so launch, but only with payer access secured.

Prompt: A mid-size biotech has just completed a successful Phase III trial for a new therapy for a chronic autoimmune condition. Should it launch the therapy itself, and is the launch financially attractive?

Step 1: Clarify, then structure out loud

"Two quick clarifications: are we deciding both whether to launch and how (build versus partner), and is the goal peak revenue, profit or a return hurdle?" Assume the answer is profit, with both questions in scope.

Then present the structure:

• Market. How many patients can we realistically treat?
• Access and pricing. What net price will payers accept?
• Competition. Who else is in the space, and how long is our patent runway?
• Economics and capabilities. Can we make money, and do we have the sales force to launch alone?
• Risks. Clinical, regulatory and payer.

State your first move: "I will start with the market to see if the prize is big enough to justify the rest."

Step 2: Request data and size the market

Ask for the numbers. Suppose the interviewer confirms:

• US diagnosed prevalence: 1,000,000 patients
• Eligible (moderate to severe, failed first-line therapy): 20 percent
• Of eligible patients, reachable and treated: 50 percent
• Realistic peak share against two entrenched competitors: 12 percent
• Net price per patient per year, after discounts: $30,000

Peak revenue is about $360 million a year: a real prize, worth continuing.

Step 3: Test the economics

Request the cost structure. Suppose:

• Gross margin (a biologic with cost of goods about 15 percent): 85 percent
• Annual sales, marketing and field force for a specialty launch: $120M
• R&D is already sunk (Phase III complete)

With roughly a decade of patent runway before exclusivity ends, the cumulative value clearly justifies a launch. The economics work at peak.

Step 4: Find the real decision

The number that decides this case is access, not the math. At $30,000 a year, payers will scrutinize formulary placement, and the 12 percent share assumes major payers cover the drug. If access slips and share falls to 6 percent, peak revenue halves to about $180 million, and peak profit drops to about $33 million after the same $120 million cost base: far less attractive and far riskier.

The second decision is build versus partner. A mid-size biotech may have no specialty sales force or payer relationships, and building them is the $120 million annual cost plus a major execution risk.

Step 5: Recommend

"Launch the therapy: at realistic share it earns about $186 million of peak annual profit over a roughly ten-year patent window, which more than justifies the launch cost. But the decision hinges on payer access, so I would make a full self-launch contingent on formulary coverage with at least two major payers within 12 months. If access looks slow, I would partner with or license to a company that already has the field force and payer relationships, trading some upside for a faster, lower-risk launch. The risk to watch is erosion of the net price through discounts, which can quietly break the economics."

Now run a pharma operations case yourself: Genome Bio, a biomaterials maker, is deciding whether to move supply to Mexico.

How should you prepare for an IQVIA case interview?

Three to four weeks: the candidate-led format and pharma basics first, then sizing and launch cases, then the written case, then full mock rounds.

IQVIA's own interview tips add three habits worth copying: study the job description, look up your interviewers on LinkedIn, and send each of them a thank-you note afterwards. The fastest way to learn the candidate-led format is repetition with feedback: run pharma launch, sizing and pricing cases, then fix the gaps the feedback finds. The case interview frameworks guide and case interview math practice cover the general skills.

Sources

• CaseBasix: IQVIA case interview (rounds, interview lengths, candidate-led format, written case, case types, behavioral and screening questions, 3 to 4 week timeline; updated August 20, 2026, checked November 3, 2026)
• IQVIA: 2024 Spring Campus Recruitment for Strategy Life Sciences Consulting SEA (Modern Hire video screen, two case rounds, partner fit interview, degree requirements, 2023 interview dates; IQVIA document dated November 9, 2023, hosted by Universiti Kebangsaan Malaysia's career office, checked November 3, 2026)
• IQVIA: Fourth quarter and full year 2025 results ($16.31 billion 2025 revenue; February 5, 2026)
• IQVIA Holdings: 2025 annual report (about 93,000 employees in more than 100 countries)
• Wikipedia: IQVIA (2016 Quintiles and IMS Health merger, Durham headquarters; checked November 3, 2026)
• IQVIA: How to ace an interview at IQVIA (job description, LinkedIn research, thank-you notes; checked November 4, 2026)
• IQVIA: Candidate frequently asked questions (application steps, Workday status check, AI use, referrals, 2026 recognitions; checked November 4, 2026)
• Glassdoor: IQVIA interview reviews (candidate reports of aptitude tests and group cases in some offices)